Neuropsychiatric symptoms in Alzheimer’s disease: associations with caregiver burden and treatment outcomes
Authors:
- 10 April 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 110 (9) , 565-570
Abstract
Background: Caregivers play a major role in providing care for patients with Alzheimer’s disease (AD) and are themselves at higher risk of health comorbidities. Aim: To address the impact of neuropsychiatric symptoms of patients in different stages of AD on their caregivers’ burden. Design: This prospective study enrolled 260 AD patients with clinical dementia rating (CDR) of 0.5, 1 and 2 at a tertiary medical center. Methods: All patients were tested using the mini-mental state examination (MMSE), the cognitive abilities screening instrument (CASI), the neuropsychiatric inventory (NPI) and the CDR scale. Data regarding therapeutic outcomes of anti-Alzheimer’s drugs were also collected. Caregivers were tested using NPI. Results: The mean follow-up interval was 25.0 ± 12.2 months, and two patients died during follow-up. NPI-burden was positively correlated with NPI-sum (r = 0.822, P < 0.001) but negatively correlated with years of education (r = −0.140, P = 0.024), CASI score (r = −0.259, P < 0.001) and MMSE score (r = −0.262, P P = 0.001 and P= 0.005, respectively). Conclusions: The severity of neuropsychiatric symptoms in patients with AD was positively associated with caregiver’s stress, and patients with better cognitive functions, under treatment with anti-Alzheimer’s drugs, had better therapeutic outcomes. To reduce the impact of neuropsychiatric symptoms, it is crucial to detect dementia in its early phases and provide early intervention with anti-Alzheimer’s drugs, which might help decrease the caregiver burden, thereby improving their quality of life.Keywords
Funding Information
- National Science Council (104-2314-B-182A-026-MY2)
This publication has 30 references indexed in Scilit:
- Caregiver Burden in Frontotemporal Degeneration and Corticobasal SyndromeDementia and Geriatric Cognitive Disorders, 2013
- Prevalence Studies of Dementia in Mainland China, Hong Kong and Taiwan: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Epidemiology of Alzheimer diseaseNature Reviews Neurology, 2011
- Validating the Chinese version of the Verbal Learning Test for screening Alzheimer’s diseaseJournal of the International Neuropsychological Society, 2009
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes ScoresArchives of Neurology, 2008
- Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stressJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementiaJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Improving the Screening Power of the Cognitive Abilities Screening Instrument, Chinese VersionDementia and Geriatric Cognitive Disorders, 2004
- The Neuropsychiatric InventoryNeurology, 1994
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982